Literature DB >> 354634

Pulmonary disease and drug kinetics.

P du Souich, A J McLean, D Lalka, S Erill, M Gibaldi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 354634     DOI： 10.2165/00003088-197803040-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  62 in total

1.  Effect of smoking on theophylline disposition.

Authors:  S N Hunt; W J Jusko; A M Yurchak
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

2.  Tissue binding of drugs.

Authors:  M Gibaldi; P J McNamara
Journal:  J Pharm Sci       Date:  1977-08       Impact factor: 3.534

Review 3.  Drug disposition and liver disease.

Authors:  G R Wilkinson; S Schenker
Journal:  Drug Metab Rev       Date:  1975       Impact factor: 4.518

4.  Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance.

Authors:  M W Weinberger; R A Matthay; E J Ginchansky; C A Chidsey; T L Petty
Journal:  JAMA       Date:  1976-05-10       Impact factor: 56.272

5.  Alteration of rat brain catecholamine metabolism during exposure to hypobaric hypoxia.

Authors:  A Cymerman; S M Robinson; D McCullough
Journal:  Can J Physiol Pharmacol       Date:  1972-04       Impact factor: 2.273

6.  Half-life of tolbutamide in patients with chronic respiratory failure.

Authors:  E Sotaniemi; P Arvela; E Huhti; O Koivisto
Journal:  Eur J Clin Pharmacol       Date:  1971-12       Impact factor: 2.953

7.  Altitude-induced alterations in drug action and metabolism.

Authors:  J H Merritt; M A Medina
Journal:  Life Sci       Date:  1968-11-01       Impact factor: 5.037

Review 8.  Cor pulmonale (pulmonary heart disease): present-day status.

Authors:  M I Ferrer
Journal:  Am Heart J       Date:  1975-05       Impact factor: 4.749

9.  Transient cardiac arrhythmias after single daily maintenance doses of digoxin.

Authors:  V Manninen; P Reissell; E Paukkala
Journal:  Clin Pharmacol Ther       Date:  1976-09       Impact factor: 6.875

Review 10.  Digitalis in pulmonary heart disease (cor pulmonale).

Authors:  J E Doherty; J J Kane; J R Phillips; J S Adamson
Journal:  Drugs       Date:  1977-02       Impact factor: 9.546
View more
  13 in total

Review 1.  Clinical pharmacology of the perinatal period and early infancy.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 2.  Hepatic first-pass metabolism in liver disease.

Authors:  T F Blaschke; P C Rubin
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

Review 3.  Influence of thyroid dysfunction on drug pharmacokinetics.

Authors:  G M Shenfield
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

Review 4.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

5.  Enhanced drug metabolism in young children with cystic fibrosis.

Authors:  A C Parker; P Pritchard; T Preston; R L Smyth; I Choonara
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

Review 6.  Role of the lung in total body clearance of circulating drugs.

Authors:  R A Roth; D A Wiersma
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

Review 7.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 8.  Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review.

Authors:  J G Gambertoglio; W J Amend; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

9.  The role of the liver in theophylline elimination.

Authors:  R E Brashear; R L Nelson; M R Glick; T O Oei; R E DeAtley
Journal:  Lung       Date:  1980       Impact factor: 2.584

Review 10.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.